Sodium Phenylbutyrate Powder Recalled for Failed Impurities Specifications
SigmaPharm Laboratories is recalling Sodium Phenylbutyrate powder nationwide due to out-of-specification impurity results found during routine testing. Affected bottles have specific lot numbers and expiration dates ranging from May 2023 to May 2024.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard involves failed impurity specifications detected through routine testing—a quality control issue without documented harm. This qualifies as a moderate-severity precautionary recall under the rubric.
Plain-English summary
SigmaPharm Laboratories LLC is recalling 1,993 bottles of Sodium Phenylbutyrate powder (NDC 42794-086-14) distributed nationwide in the USA. The recall was initiated because routine testing identified out-of-specification impurity results that failed to meet established quality standards.
The affected product is a prescription oral powder supplied in 250-gram bottles. The recall involves multiple lot numbers: 1813001, 1813101, 1813201 (expiring May 2023); 1822601, 1822701 (expiring November 2023); and 1905701, 1905801, 1906501, 1906601, 1906701 (expiring May 2024).
Consumers and healthcare providers in possession of affected bottles should stop use and contact their pharmacy or healthcare provider for guidance. Patients should not discontinue use of this medication without first consulting their healthcare provider, as this drug is used to manage metabolic conditions and requires medical supervision.
The recalled product
- Product
- Sodium Phenylbutyrate POWDER, 250 grams bottle, Rx Only, Sigmapharm Laboratories, LLC Bensalem, PA 19020 NDC 42794-086-14 UPC Code# 3 42794 086 14 4
- Manufacturer
- SigmaPharm Laboratories LLC
- Category
- Drug — Prescription Oral Powder
- Affected units
- 1,993
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot Numbers: 1813001
- 1813101
- 1813201
- EXP. May 2023
- 1822601
- 1822701
- EXP Nov 2023
- 1905701
- 1905801
- 1906501
- 1906601
- 1906701
- EXP May 2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · SigmaPharm Laboratories LLC
See all →- ModerateSodium Phenylbutyrate Powder Recalled for Impurity Specification Failures
FDA (Drugs) · 2021-10-06
- LowSigmaPharm Recalls Asenapine Tablets Due to Incorrect Flavoring Agent
FDA (Drugs) · 2021-05-26
- LowSigmaPharm Recalls Asenapine Tablets Due to Incorrect Flavoring Agent
FDA (Drugs) · 2021-05-26
- ModerateSigmaPharm Recalls Liothyronine Sodium Tablets Due to Cross-Contamination
FDA (Drugs) · 2014-05-28